Filing Details

Accession Number:
0001179110-17-011478
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-14 19:57:56
Reporting Period:
2017-08-11
Filing Date:
2017-08-14
Accepted Time:
2017-08-14 19:57:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1583107 Theravance Biopharma Inc. TBPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184677 G Burton Malkiel C/O Theravance Biopharma Us, Inc.
901 Gateway Boulevard
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2017-08-11 15,000 $24.59 47,571 No 4 P Direct
Ordinary Shares Acquisiton 2017-08-11 15,000 $24.59 15,000 No 4 P Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By Spouse
Footnotes
  1. Represents the weighted average purchase price per share for the open market purchase on August 11, 2017. The shares were purchased at prices ranging from $24.35 to $24.921 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  2. Represents the weighted average purchase price per share for the open market purchase on August 11, 2017. The shares were purchased at prices ranging from $24.36 to $24.903 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.